Folgen
Yoseph Atilaw
Yoseph Atilaw
Senior Research Scientist
Bestätigte E-Mail-Adresse bei astrazeneca.com - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses
A Luttens, H Gullberg, E Abdurakhmanov, DD Vo, D Akaberi, VO Talibov, ...
Journal of the American Chemical Society 144 (7), 2905-2920, 2022
1612022
Solution conformations shed light on PROTAC cell permeability
Y Atilaw, V Poongavanam, C Svensson Nilsson, D Nguyen, A Giese, ...
ACS Medicinal Chemistry Letters 12 (1), 107-114, 2020
1122020
Linker-dependent folding rationalizes PROTAC cell permeability
V Poongavanam, Y Atilaw, S Siegel, A Giese, L Lehmann, D Meibom, ...
Journal of Medicinal Chemistry 65 (19), 13029-13040, 2022
522022
Predicting the permeability of macrocycles from conformational sampling–limitations of molecular flexibility
V Poongavanam, Y Atilaw, S Ye, LHE Wieske, M Erdelyi, G Ermondi, ...
Journal of Pharmaceutical Sciences 110 (1), 301-313, 2021
382021
Chemical investigation of Lawsonia inermis L. leaves from Afar region, Ethiopia
T Kebedekidanemariam, TK Tesema, KH Asressu, AD Boru
Orient J Chem 29 (3), 1129-1134, 2013
332013
Cell permeability of isomeric macrocycles: Predictions and NMR studies
F Begnini, V Poongavanam, Y Atilaw, M Erdelyi, S Schiesser, J Kihlberg
ACS Medicinal Chemistry Letters 12 (6), 983-990, 2021
222021
Four Prenylflavone Derivatives with Antiplasmodial Activities from the Stem of Tephrosia purpurea subsp. leptostachya
Y Atilaw, L Muiva-Mutisya, A Ndakala, HM Akala, R Yeda, YJ Wu, P Coghi, ...
Molecules 22 (9), 1514, 2017
192017
Three Chalconoids and a Pterocarpene from the Roots of Tephrosia aequilata
Y Atilaw, S Duffy, M Heydenreich, L Muiva-Mutisya, VM Avery, M Erdélyi, ...
Molecules 22 (2), 318, 2017
182017
Conformation of the macrocyclic drug lorlatinib in polar and nonpolar environments: a MD simulation and NMR study
C Peng, Y Atilaw, J Wang, Z Xu, V Poongavanam, J Shi, J Kihlberg, ...
ACS omega 4 (26), 22245-22250, 2019
172019
Strategic management practices and performance of small and medium sized enterprises in Kenya
GK Njeru
172015
3-Oxo-14α,15α,epoxyschizozygine: A new schizozygane indoline alkaloid from Schizozygia coffaeoides
Y Atilaw, M Heydenreich, A Ndakala, HM Akala, E Kamau, A Yenesew
Phytochemistry Letters 10, 28-31, 2014
162014
Antiplasmodial prenylated flavanonols from Tephrosia subtriflora
LM Muiva-Mutisya, Y Atilaw, M Heydenreich, A Koch, HM Akala, ...
Natural product research 32 (12), 1407-1414, 2018
142018
Determination of Levels of Cathine in Khat (Catha edulis) Leaves and its Detection in Urine of Khat Chewers: A Preliminary Report
Y Atilaw, E Dagne, Y Adugna, E Kebede
Sous presse, 2010
14*2010
Prospects of sustainable natural resource management and livelihood development in Wondo Genet area, southern Ethiopia
TG Ango
Addis Ababa University, 2005
132005
Going viral: an investigation into the chameleonic behaviour of antiviral compounds
LHE Wieske, Y Atilaw, V Poongavanam, M Erdélyi, J Kihlberg
Chemistry–A European Journal 29 (8), e202202798, 2023
102023
Biflavanones, Chalconoids, and Flavonoid Analogues from the Stem Bark of Ochna holstii
TM Kalenga, MM Ndoile, Y Atilaw, PJ Gilissen, JJE Munissi, A Rudenko, ...
Journal of Natural Products 84 (2), 364-372, 2021
72021
Prenylated Flavonoids from the Roots of Tephrosia rhodesica
Y Atilaw, L Muiva-Mutisya, J Bogaerts, S Duffy, A Valkonen, ...
Journal of Natural Products 83 (8), 2390-2398, 2020
72020
Antiviral iridoid glycosides from Clerodendrum myricoides
D Umereweneza, JT Molel, J Said, Y Atilaw, T Muhizi, E Trybala, ...
Fitoterapia 155, 105055, 2021
62021
Antibacterial and cytotoxic biflavonoids from the root bark of Ochna kirkii
TM Kalenga, MM Ndoile, Y Atilaw, JJE Munissi, PJ Gilissen, A Rudenko, ...
Fitoterapia 151, 104857, 2021
62021
Antibacterial and cytotoxic prenylated dihydrochalcones from Eriosema montanum
D Umereweneza, Y Atilaw, A Rudenko, Y Gütlin, C Bourgard, AK Gupta, ...
Fitoterapia 149, 104809, 2021
62021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20